Pieris Pharmaceuticals Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 15:17

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Dellora Investments LP
2. Date of Event Requiring Statement (Month/Day/Year)
2024-11-06 		3. Issuer Name and Ticker or Trading Symbol
PIERIS PHARMACEUTICALS, INC. [PIRS]
(Last) (First) (Middle)
283 GREENWICH AVENUE , 3RD FLOOR
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
GREENWICH CT 06830
6. Individual or Join/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dellora Investments LP
283 GREENWICH AVENUE
3RD FLOOR
GREENWICH, CT06830
X

Signatures

Dellora Investments LP, /s/ Kevin Pyun, Principal, Dellora Investments GP LLC, its General Partner 2024-11-18
**Signature of Reporting Person Date
Kevin Pyun, /s/ Kevin Pyun 2024-11-18
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reporting persons are Dellora Investments LP ("Dellora") and Mr. Kevin Pyun. Dellora is the investment adviser to private funds managed by Dellora that hold securities directly for the benefit of their investors. Dellora may be deemed to beneficially own such securities indirectly as the investment adviser of the private funds and Mr. Pyun may be deemed to beneficially own them indirectly as the control person of Dellora. Each of Dellora and Mr. Pyun disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.